Value-based care: misunderstood, but making a difference
Too often, value-based care’s successes are obscured by jargon and policy complexity, says Mara McDermott, CEO of advocacy group Accountable for Health.
Related Articles
The FDA clearances for medical devices you need to know
The FDA clears Stryker and Zimmer Biomet devices and two radiology imaging scanners.
Cityblock CEO details opportunities in tax law’s Medicaid cuts
Cityblock Health CEO Dr. Toyin Ajayi expects demand for the Medicaid-focused provider to rise despite Congress slashing $940 billion from the program.
CMS is taking a stab at site-neutral payment. Here’s what to know
The hospital industry is in for a fight.
Henry Ford Health, Michigan State University launch $10M VC fund
The fund will invest in a range of healthcare startups, including those focused on artificial intelligence and medical devices.
FDA issues alert for Baxter’s Novum infusion pumps
Problems with the pumps are potentially associated with 79 serious injuries and two deaths, according to Baxter.
Immigration policies threaten post-acute care access
Haitian immigrants had worked for nursing homes and home health companies have started leaving the U.S, according to providers.
Aidoc nabs $150M from General Catalyst, health system investors
Aidoc becomes the latest AI startup to receive more than $100 million in venture capital funding this year.
CMS is taking a stab at site-neutral payment. Here’s what to know
The hospital industry is in for a fight.
Hear from Advocate, Ascension and Philips at our Leadership Summit
The conference, taking place Sept. 25 in Washington, D.C., will feature executives from health systems, insurers and device manufacturers, among others.
Medicare doctor pay plan would hit specialists, curb AMA clout
Medicare fees for nearly 9,000 billing codes mainly associated with speciality care would decline 2.5% under a proposed rule.